# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-17-001159
Filing Date
2017-02-27
Accepted
2017-02-27 16:04:25
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | f10k_022717p.htm | 10-K | 1034777
2 | EXHIBIT 10.74 | exh_1074.htm | EX-10.74 | 494
3 | EXHIBIT 10.77 | exh_1077.htm | EX-10.77 | 1804
4 | EXHIBIT 21 | exh_21.htm | EX-21 | 2285
5 | EXHIBIT 23 | exh_23.htm | EX-23 | 11398
6 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 6925
7 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 6945
8 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4020
9 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 4149
16 | GRAPHIC | graph.jpg | GRAPHIC | 91035
17 | GRAPHIC | exh1074_1.jpg | GRAPHIC | 281006
18 | GRAPHIC | exh1077_1.jpg | GRAPHIC | 263430
19 | GRAPHIC | exh1077_2.jpg | GRAPHIC | 261900
20 | GRAPHIC | exh1077_3.jpg | GRAPHIC | 150954
| Complete submission text file | 0001171843-17-001159.txt |  | 7741657

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE FILE | bcrx-20161231.xml | EX-101.INS | 1200594
11 | XBRL SCHEMA FILE | bcrx-20161231.xsd | EX-101.SCH | 75321
12 | XBRL CALCULATION FILE | bcrx-20161231_cal.xml | EX-101.CAL | 60208
13 | XBRL DEFINITION FILE | bcrx-20161231_def.xml | EX-101.DEF | 513755
14 | XBRL LABEL FILE | bcrx-20161231_lab.xml | EX-101.LAB | 462602
15 | XBRL PRESENTATION FILE | bcrx-20161231_pre.xml | EX-101.PRE | 533774

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 17641648
SIC: 2836 Biological Products, (No Diagnostic Substances)